PortfoliosLab logoPortfoliosLab logo
INSM vs. VRNA
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

INSM vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Insmed Incorporated (INSM) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

INSM vs. VRNA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
INSM
Insmed Incorporated
-6.04%152.09%122.78%55.11%-26.65%-18.17%39.41%82.01%-57.92%66.12%
VRNA
Verona Pharma plc
0.00%130.21%133.60%-23.92%288.84%-4.00%21.74%-40.41%-18.71%-12.07%

Fundamentals

Market Cap

INSM:

$34.93B

VRNA:

$9.72B

EPS

INSM:

-$6.23

VRNA:

-$0.69

PS Ratio

INSM:

55.22

VRNA:

57.97

PB Ratio

INSM:

47.27

VRNA:

34.92

Total Revenue (TTM)

INSM:

$606.42M

VRNA:

$167.65M

Gross Profit (TTM)

INSM:

$483.49M

VRNA:

$159.52M

EBITDA (TTM)

INSM:

-$1.19B

VRNA:

-$40.86M

Returns By Period


INSM

1D
6.65%
1M
9.50%
YTD
-6.04%
6M
13.55%
1Y
114.34%
3Y*
112.46%
5Y*
35.77%
10Y*
29.16%

VRNA

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INSM vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INSM
INSM Risk / Return Rank: 8989
Overall Rank
INSM Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
INSM Sortino Ratio Rank: 9292
Sortino Ratio Rank
INSM Omega Ratio Rank: 9292
Omega Ratio Rank
INSM Calmar Ratio Rank: 8787
Calmar Ratio Rank
INSM Martin Ratio Rank: 8484
Martin Ratio Rank

VRNA
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INSM vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Insmed Incorporated (INSM) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INSMVRNADifference

Sharpe ratio

Return per unit of total volatility

2.16

Sortino ratio

Return per unit of downside risk

3.03

Omega ratio

Gain probability vs. loss probability

1.42

Calmar ratio

Return relative to maximum drawdown

3.07

Martin ratio

Return relative to average drawdown

7.39

INSM vs. VRNA - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


INSMVRNADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.50

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.37

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.00

Correlation

The correlation between INSM and VRNA is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

INSM vs. VRNA - Dividend Comparison

Neither INSM nor VRNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

INSM vs. VRNA - Drawdown Comparison


Loading graphics...

Drawdown Indicators


INSMVRNADifference

Max Drawdown

Largest peak-to-trough decline

-98.65%

Max Drawdown (1Y)

Largest decline over 1 year

-35.67%

Max Drawdown (5Y)

Largest decline over 5 years

-54.85%

Max Drawdown (10Y)

Largest decline over 10 years

-64.84%

Current Drawdown

Current decline from peak

-22.65%

Average Drawdown

Average peak-to-trough decline

-86.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.84%

Volatility

INSM vs. VRNA - Volatility Comparison


Loading graphics...

Volatility by Period


INSMVRNADifference

Volatility (1M)

Calculated over the trailing 1-month period

15.95%

Volatility (6M)

Calculated over the trailing 6-month period

35.51%

Volatility (1Y)

Calculated over the trailing 1-year period

53.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

72.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.16%

Financials

INSM vs. VRNA - Financials Comparison

This section allows you to compare key financial metrics between Insmed Incorporated and Verona Pharma plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
263.84M
75.14M
(INSM) Total Revenue
(VRNA) Total Revenue
Values in USD except per share items